Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma

7 May 2023

Abstract excerpt

Primary Sjogren syndrome (pSS) is the second most common autoimmune disorder worldwide, which, in the worst scenario, progresses to Non-Hodgkin Lymphoma (NHL). Despite extensive studies, there is still a lack of knowledge about developing pSS for NHL. This study focused on cells’ signaling in pSS progression to the NHL type of diffuse large B-cell lymphoma (DLBCL). Using bulk RNA and single cell analysis, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to Salivary Gland Disorders and Functions
Share to Salivary Gland Tumors Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37176092
DOI: 10.3390/ijms24098385

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell LymphomaPMID 37176092Read ↗

Transcriptomics explores potential mechanisms for the development of Primary Sjogren’s syndrome to diffuse large B-cell lymphoma in B cellsSemantic proximity Read ↗

Sjögren's syndrome: one year in review 2022Semantic proximity Read ↗

Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.Semantic proximity Read ↗

Sjögren's syndrome: one year in review 2023Semantic proximity Read ↗

Recent advances in primary Sjogren's syndromeSemantic proximity Read ↗

Analysis of Gene Expression and TCR/B Cell Receptor Profiling of Immune Cells in Primary Sjögren’s Syndrome by Single-Cell SequencingSemantic proximity Read ↗

New Insights into Lymphoma PathogenesisSemantic proximity Read ↗

KLRB1 defines an activated phenotype of CD4+ T cells and shows significant upregulation in patients with primary Sjögren's syndrome.Semantic proximity Read ↗

Pathogenesis of Sjögren's disease: one year in review 2024.Semantic proximity Read ↗

Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s SyndromeSemantic proximity Read ↗

Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatmentSemantic proximity Read ↗

Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.